Pelvic Organ Prolapse Repair Device Market Size, Share & COVID-19 Impact Analysis - Global - 2021-2027 - MedCore - Segmented by: Transvaginal Mesh Market & Sacrocolpopexy Mesh Market
The global pelvic organ prolapse repair device market size is estimated to increase over the forecast period to reach $180.1 million by 2027.
Leading participants in the global market share for pelvic organ prolapse repair devices include Boston Scientific, Coloplast, and Caldera Medical. This comprehensive international market analysis covers more than 70 countries, encompassing both the transvaginal mesh and sacrocolpopexy mesh segments.
Pelvic organ prolapse (POP) affects approximately half of women who have undergone childbirth or menopause. Despite this, the overall market for pelvic organ prolapse repair devices has exhibited a downward trend in recent years and is anticipated to undergo a significant reduction throughout the forecast period, barring fluctuations attributable to the COVID-19 pandemic.
MARKET DATA INCLUDEDUnit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2027, and Historical Data to 2017
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
PROCEDURE NUMBERSIn the course of examining the pelvic organ prolapse repair device market, iData Research has conducted a thorough assessment of procedure figures pertaining to transvaginal mesh repair and sacrocolpopexy mesh repair. This meticulous analysis aims to enhance the precision of our market estimation, furnishing you with procedural volume data spanning a decade and encompassing 70 countries.
PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET INSIGHTSThe North American region emerged as the primary hub for pelvic organ prolapse repair devices. A modest surge is anticipated in the sacrocolpopexy market, attributed to stable procedure rates and the notable transition away from transvaginal mesh utilization. The sales volume of transvaginal mesh has dwindled due to its associated adverse effects and heightened focus on patient well-being. Furthermore, a substantial downturn is foreseen during the projected period, excluding variations linked to COVID-19, as elaborated extensively in the report.
MARKET SHARE INSIGHTSThe global pelvic organ prolapse repair device market was controlled by Boston Scientific, Coloplast, and Caldera Medical.
Securing the top stance in the pelvic organ prolapse repair device market, Boston Scientific commanded a dominant presence through its range of products. This comprehensive portfolio encompasses the Upsylon™ Y-Mesh, serving as a bridging material for sacrocolpopexy in vaginal vault prolapse treatment. Additionally, the Colpassist™ vaginal positioning device facilitates mesh placement during procedures, while other offerings are thoroughly examined in the report.
RESEARCH REGIONAL COVERAGEThroughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
North America (the United States and Canada)
Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)